explore -WSS

explore

author：knowledge 2025-09-28 23:11:49 - browse：751

Three Wegovy injection pens in a row — first opinion coverage from STAT — Adobe

Novo Nordisk will test whether its GLP-1 drugs can help people with alcohol-associated liver disease, and, as part of that, will study if the treatments will change the amount of alcohol people drink.

This appears to be the first time the company is getting involved in research to see if the booming class of GLP-1 diabetes and obesity drugs can affect substance consumption, a question that academic researchers have been probing but the pharmaceutical industry has so far avoided.

The nine-month study will try three drugs alone and in combinations against placebo. The primary outcome being tested is change in liver scarring, or fibrosis, and one of the secondary outcomes is changes in alcohol consumption. The news of the study was first reported by Bloomberg.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： 5 wounded, 2 critically, in Michigan shopping center shooting

hotspot

knowledge

WSS

HHS suspends federal funding for EcoHealth Alliance

Boston hospital trains restaurant workers on naloxone for overdoses

Adidas to release second batch of Yeezy sneakers after breakup with Ye

Poland's lawmakers approve a divisive law on Russian influence

Russian and Belarusian players banned from a women's tennis tournament in Prague

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

entertainment

Continuity nursing helped my family in our darkest PICU moments

Fertility clinic egg and embryo storage is a disaster

Dobbs anniversary: the lost opportunity of abortion as health care

STAT series 'Denied by AI' wins major journalism prizes

How to save PrEP access — and even expand it

WuXi Biologics execs register to lobby as Congress comes for the company

Walensky prepares to leave CDC — and Congress — behind

Adidas to release second batch of Yeezy sneakers after breakup with Ye

In Memoriam: Notable people who died in 2023

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

explore

Fertility clinic egg and embryo storage is a disaster

WuXi Biologics execs register to lobby as Congress comes for the company

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

What a koala virus tells us about the human genome

HCA says smaller share of spending going to labor

Typhoon Doksuri makes landfall in China after bringing deadly landslides to Philippines

hotspot

focus

knowledge

explore